
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- Analyst Ratings
Upturn AI SWOT
- About
LifeMD Inc (LFMD)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
06/27/2025: LFMD (3-star) is a STRONG-BUY. BUY since 41 days. Profits (86.82%). Updated daily EoD!
Year Target Price $12.62
Year Target Price $12.62
6 | Strong Buy |
1 | Buy |
1 | Hold |
0 | Under performing |
0 | Sell |
Analysis of Past Performance
Type Stock | Historic Profit 216.14% | Avg. Invested days 35 | Today’s Advisory Strong Buy |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 624.90M USD | Price to earnings Ratio - | 1Y Target Price 13.33 |
Price to earnings Ratio - | 1Y Target Price 13.33 | ||
Volume (30-day avg) - | Beta 2.43 | 52 Weeks Range 3.99 - 15.84 | Updated Date 06/29/2025 |
52 Weeks Range 3.99 - 15.84 | Updated Date 06/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.33 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -4.59% | Operating Margin (TTM) 3.87% |
Management Effectiveness
Return on Assets (TTM) -6.88% | Return on Equity (TTM) -2243.07% |
Valuation
Trailing PE - | Forward PE 80.65 | Enterprise Value 615610062 | Price to Sales(TTM) 2.67 |
Enterprise Value 615610062 | Price to Sales(TTM) 2.67 | ||
Enterprise Value to Revenue 2.63 | Enterprise Value to EBITDA 235.07 | Shares Outstanding 45447600 | Shares Floating 36996622 |
Shares Outstanding 45447600 | Shares Floating 36996622 | ||
Percent Insiders 15.99 | Percent Institutions 37.46 |
Analyst Ratings
Rating 4.62 | Target Price 12.62 | Buy 1 | Strong Buy 6 |
Buy 1 | Strong Buy 6 | ||
Hold 1 | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
LifeMD Inc
Company Overview
History and Background
LifeMD Inc. (formerly Conversion Labs) was founded in 2019. It focuses on telehealth services, offering virtual primary care and specialized treatment for various conditions. The company has grown through acquisitions and organic expansion of its service offerings.
Core Business Areas
- Telehealth Services: Provides virtual consultations, diagnosis, and treatment for conditions like men's and women's health, dermatology, and weight management.
- Direct-to-Consumer Products: Offers products related to its telehealth offerings, such as prescription medications, supplements, and skincare products.
- Digital Marketing and Customer Acquisition: Utilizes digital marketing strategies to acquire and retain customers for its telehealth platform.
Leadership and Structure
The leadership team consists of experienced executives in telehealth, marketing, and finance. The organizational structure involves different departments focusing on telehealth operations, marketing, technology, and customer service. CEO is Justin Schreiber.
Top Products and Market Share
Key Offerings
- Virtual Primary Care: Offers general medical consultations and ongoing care management. Competitors include Teladoc (TDOC) and Amwell (AMWL). Revenue is not readily available in published market share reports.
- Men's Health Treatments: Provides telehealth services and prescription medications for conditions like erectile dysfunction and hair loss. Competitors include Hims & Hers Health (HIMS). Revenue is not readily available in published market share reports.
- Weight Management Programs: Provides telehealth support and prescription medications for weight loss. Competitors include WW International (WW). Revenue is not readily available in published market share reports.
Market Dynamics
Industry Overview
The telehealth industry is experiencing rapid growth due to increased adoption of virtual healthcare services and advancements in technology. The market is becoming more competitive with the entry of new players and expansion of existing telehealth platforms.
Positioning
LifeMD Inc. is positioned as a provider of comprehensive telehealth solutions with a focus on specific conditions and direct-to-consumer marketing. The company aims to differentiate itself through personalized care and convenient access to healthcare services.
Total Addressable Market (TAM)
The global telehealth market is projected to reach hundreds of billions of dollars in the coming years. LifeMD is positioned to capture a portion of this market through its specialized services and marketing efforts.
Upturn SWOT Analysis
Strengths
- Strong brand reputation
- Effective digital marketing strategies
- Growing customer base
- Diverse telehealth service offerings
- Experienced management team
Weaknesses
- Reliance on digital marketing for customer acquisition
- High customer acquisition costs
- Competition from larger telehealth providers
- Profitability challenges
- Negative cash flows
Opportunities
- Expansion into new telehealth services
- Partnerships with healthcare providers and insurance companies
- Geographic expansion
- Increased adoption of telehealth
- Technological advancements in telehealth
Threats
- Increased competition
- Changes in healthcare regulations
- Data privacy and security concerns
- Economic downturn
- Consumer resistance to telehealth
Competitors and Market Share
Key Competitors
- TDOC
- HIMS
- AMWL
Competitive Landscape
LifeMD Inc. faces competition from larger telehealth providers and established healthcare companies. The company's competitive advantages include its focus on specific conditions and direct-to-consumer marketing. However, the company needs to address its weaknesses in profitability and customer acquisition costs to compete effectively.
Growth Trajectory and Initiatives
Historical Growth: LifeMD Inc. has experienced rapid revenue growth in recent years due to increased adoption of its telehealth services and successful marketing campaigns.
Future Projections: Future growth projections for LifeMD Inc. are dependent on market conditions, competition, and the company's ability to execute its growth strategy. Analyst estimates should be referenced for the projections.
Recent Initiatives: Recent initiatives undertaken by LifeMD Inc. include the expansion of its telehealth services, partnerships with healthcare providers, and investments in technology.
Summary
LifeMD Inc. is a telehealth company experiencing revenue growth but faces challenges to acheive profitability. The company's strengths include a direct-to-consumer model but high acquisition costs are a weakness. Successfully expanding services and partnerships will be key. Management will need to watch out for larger competitors and changes in telehealth regulations.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Website
- Public Financial Statements
- Third-Party Market Research Reports
Disclaimers:
The information provided is for informational purposes only and should not be considered financial advice. Market share data is not currently readily available.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About LifeMD Inc
Exchange NASDAQ | Headquaters New York, NY, United States | ||
IPO Launch date 2001-01-02 | Chairman & CEO Mr. Justin Schreiber | ||
Sector Healthcare | Industry Health Information Services | Full time employees 304 | Website https://lifemd.com |
Full time employees 304 | Website https://lifemd.com |
LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company operates through two operating segments: Telehealth and WorkSimpli. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs, including erectile dysfunction, premature ejaculation, and hair loss; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; and Cleared which provides personalized treatments for allergy, asthma and immunology. It also provides LifeMD PC, a virtual primary care and telehealth service which is a provider for their primary care, urgent care, and chronic care needs; and offers virtual medical care, including on-demand consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, integration with in-home tools, and more. In addition, the company offers PDFSimpli, an online software as a service platform that allows users to create, edit, convert, sign, and share PDF documents; ResumeBuild which provides digital resume and cover letter services; SignSimpli, a digital signature platform; and LegalSimpli, a provider of legal forms for consumers and small businesses. Further, it offers GLP-1 for weight management and in-home health monitoring devices. It sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was incorporated in 1994 and is headquartered in New York, New York.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.